Expiration Date

Expiration Date. Means the earliest to occur of (i) the fifth anniversary of the Series C-1 Conversion Date, (ii) the date on which the Company shall receive a valid "Redemption Request" (as defined in the Series C-1 Designation) delivered in accordance with Section 6.1 of the Series C-1 Designation, and (iii) provided the conditions set forth in the last sentence of Section 4.2 for termination of the Warrant are satisfied, the Liquidation Date (as defined in Section 4.2 below).

Expiration Date. The fifth anniversary of the date hereof

Expiration Date. The tenth anniversary of the Date of Grant.

Expiration Date. The ninetieth (90th) day after the occurrence of both (i) the public disclosure by the Company of the achievement of statistical significance on each of the primary endpoints for the Company's CTP-543 THRIVE-[AA1][AA2] Phase 3 clinical trial (the "THRIVE Trial") and (ii) a determination by the Company, as attested to in writing by the Company's Board of Directors adopted by resolution or unanimous written consent, that, in the Company's professional opinion based on information available as of... the date of such resolution or unanimous written consent, there are no safety or other issues that would impede the Company's filing of a New Drug Application without first requiring an additional clinical study that is not already contemplated by the Company's development plans for CTP-543 as of the Original Issue Date; provided, however, if either clause (i) or (ii) have not yet been satisfied after completion of the THRIVE Trial, then the Expiration Date shall mean the ninetieth (90th) day after the earlier of (A) the public release of topline data from two ongoing Phase 3 clinical trials being conducted by Avanir Pharmaceuticals/Otsuka Pharmaceutical (NCT04464564 and NCT04408755) in the indication of agitation in Alzheimer's disease patients and (B) the receipt by the Holder of written notification that the Company has received written notice from Avanir Pharmaceuticals/Otsuka Pharmaceutical of a decision to cease both of such clinical trials early. In the event that neither of the foregoing events in clauses (A) and (B) occur, then the Expiration Date shall be the tenth (10th) anniversary from issuance. View More

Expiration Date. The earliest to occur of (i) the close of business on June 30, 2021, (ii) the date on which the first Change of Control (as defined below) (or the "effective time" if such a time is specified in connection with the transaction constituting such Change of Control), (iii) the date that is 360 days following the closing of an IPO (as defined below) (or the "effective time" if such a time is specified in connection with the IPO), or (iv) the date that is 360 days following the date on which the... Company's Common Stock is Listed for Trading. View More